1. Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
   Noraini Abd-Aziz et al, 2016, Journal of General Virology CrossRef
2. Role of Hypoxia-Inducible Factor (HIF) in the Initiation of Cancer and Its Therapeutic Inhibitors
   Sasidhar Eda et al, 2017, Role of Transcription Factors in Gastrointestinal Malignancies CrossRef
3. Current Drugs and their Therapeutic Targets for Hypoxia-inducible Factors in Cancer
   Esha Joshi et al, 2023, Current Protein & Peptide Science CrossRef
4. Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions
   Paweł Jóźwiak et al, 2017, Journal of Biomedical Science CrossRef
5. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
   Muhlis Akman et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
6. Zinc induces normoxic accumulation of transcriptionally active hypoxia-inducible factor 1-alpha in mammary epithelial cells
   S.-Y. Lee et al, 2017, Molecular Biology CrossRef
7. Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms
   Julian Baumeister et al, 2020, Leukemia CrossRef
8. Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
   Marta Pelon et al, 2024, Frontiers in Pharmacology CrossRef
9. The relationship between MRI quantitative parameters and the expression of hypoxia inducible factor-1 alpha in cerebral astrocytoma
   Chang Shu et al, 2017, Clinical Neurology and Neurosurgery CrossRef
10. Systemic chemotherapy promotes HIF‐1α‐mediated glycolysis and IL‐17F pathways in cutaneous T‐cell lymphoma
    Bo Wang et al, 2020, Experimental Dermatology CrossRef
11. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
    Yuyang Pang et al, 2023, International Journal of Molecular Sciences CrossRef
12. PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells
    Wangyu Cai et al, 2017, Molecular Cancer Therapeutics CrossRef
13. Therapeutic Strategies to Block the Hypoxic Response
    Josh W. DiGiacomo et al, 2019, Hypoxia and Cancer Metastasis CrossRef
14. Associations between HIFs and tumor immune checkpoints: mechanism and therapy
    Jiayu Liu et al, 2024, Discover Oncology CrossRef
15. Breakthrough of solid tumor treatment: CAR-NK immunotherapy
    Wenkang Wang et al, 2024, Cell Death Discovery CrossRef
16. Focus on Hypoxia-Related Pathways in Pediatric Osteosarcomas and Their Druggability
    Marina Pierrevelcin et al, 2020, Cells CrossRef
17. Revisiting the HIF switch in the tumor and its immune microenvironment
    Sophie J. Cowman et al, 2022, Trends in Cancer CrossRef
18. Hypoxia
    Corbin C. Jensen et al, 2022, Comprehensive Pharmacology CrossRef
19. The hypoxic tumour microenvironment: A safe haven for immunosuppressive cells and a therapeutic barrier to overcome
    Wai Hoong Chang et al, 2020, Cancer Letters CrossRef